NCT01200056 - Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

June 30, 2010

Conditions

Coronary DiseaseUltrasonography, InterventionalHydroxymethylglutaryl-CoA Reductase Inhibitors

Interventions

DRUG

Atorvastatin 10mg versus 40mg.

2 arms comparing atorvastatin 10mg daily for 6 months to atorvastatin 40mg daily for 6 months. The primary endpoint would be the 6 months VH-IVUS findings and clinical outcomes.

Trial Locations (1)

Unknown

Department of Medicine, the University of Hong Kong, Queen Mary Hospital, Hospital Authority, Hong Kong SAR